Zimmer Biomet HLDS CVR

13F holders, Q4 2025 (December 31)
2holders
0new positions
0sold out
$0.00avg. 13F price*

At the end of Q4 2025, 2 institutions reported holding Zimmer Biomet HLDS CVR in their 13F filings, unchanged from Q3 2025. 0 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($0) and GAMMA Investing LLC ($0).

Company
Zimmer Biomet HLDS CVR
Filed as
PARAGON 28 INC COM CVR from 69913P105 (Q4 2025)
CUSIP
609CVR022
Latest filing quarter
Q2 2026

History

Number of 13F holders

012 Q2 2025: 1Q2 2025Q3 2025: 2Q3 2025Q4 2025: 2Q4 2025Q1 2026: 1Q1 2026Q2 2026: 2Q2 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions0$0
Exits0$0

All 13F filers, Q3 2025 → Q4 2025: 280 shares sold, net −280 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 2 holders

Rhumbline Advisers 0.00% Reduce -0.4% 67,853 $0
GAMMA Investing LLC 0.00% No change 501 $0

"% of holder's portfolio" is ZIMMER BIOMET HLDS CVR's weight in each manager's 13F, not the share of Zimmer Biomet HLDS CVR the manager owns.